This study investigates the effectiveness of an investigational medication for treating Vasomotor Symptoms (VMS), which are hot flashes, compared to a placebo. Participants will be randomly assigned to one of two study arms: one receiving the investigational medication and the other receiving a placebo.
During the study, participants will take either the investigational medication or a placebo for 28 days. After this period, there will be a 2-week follow-up without any medication to monitor symptoms before the study ends. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine.
- Who can participate: Adults with a history of or current breast cancer who are taking tamoxifen or an aromatase inhibitor can participate. They must experience at least 50 moderate to severe hot flashes per week. Eligibility is determined after a screening period.
- Study details: Participants will take either the investigational medication or a placebo daily for 28 days. After this, there will be a 2-week period without any medication to observe changes in symptoms. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand
